-+ 0.00%
-+ 0.00%
-+ 0.00%

DroneShield Stock And 2 Australian Penny Stocks With Stronger Balance Sheets

Simply Wall St·07/23/2026 15:39:53
Listen to the news

Penny stocks with healthier balance sheets can offer a middle ground between high-growth potential and extreme early-stage risk. This matters when central banks watch inflation, bond yields move with every policy hint, and oil prices keep pressure on costs. The Financially Fit Penny Stocks screener focuses on companies trading below 5 that still meet stricter financial quality checks, so you are not just chasing the lowest prices. In this article, you will see 3 of the best stocks from this screener, helping you quickly spot ideas that balance affordability with an emphasis on financial resilience.

DroneShield (ASX:DRO)

Overview: DroneShield is a Sydney based defence technology company that develops and sells hardware and software to detect, track, and disable hostile drones for military, security, and critical infrastructure customers worldwide. Its products range from wearable drone detectors to fixed-site and vehicle mounted systems used by defence agencies, airports, stadiums, and other high risk locations.

Operations: DroneShield generates about A$216.8 million in revenue from its Aerospace & Defense segment, with A$195.0 million from Australia and the rest of the world and A$29.7 million from the USA.

Market Cap: A$2.0b

DroneShield sits at the center of a fast maturing counter drone market, shifting from one off wins to repeat orders as defence and security agencies embed counter UAS into ongoing budgets. Forecast earnings growth above 50% a year and revenue growth above 20% a year highlight that investors are watching its move from early profitability toward scale. However, the current premium pricing and a P/S above many peers mean expectations are already high. A refreshed, highly independent board, including a retired Rear Admiral with deep procurement experience, could help convert more of the growing pipeline into longer term contracts. At the same time, the heavy reliance on external borrowing and an ASIC inquiry are reminders that execution and governance risks are real and worth tracking closely.

DroneShield’s shift from one off wins to repeat counter drone contracts is catching attention, but the real question is whether current expectations fully reflect what analysts see next in the analyst forecasts for DroneShield.

ASX:DRO Earnings & Revenue Growth as at Jul 2026
ASX:DRO Earnings & Revenue Growth as at Jul 2026

Sigma Healthcare (ASX:SIG)

Overview: Sigma Healthcare is an Australian pharmacy wholesaler and retailer that supplies medicines and health products to community pharmacies, franchises store networks such as Chemist Warehouse, Amcal, and Discount Drug Stores, and provides logistics and health services both in store and online.

Operations: Sigma Healthcare generates about A$9.5b in revenue from Healthcare, with A$9.2b from Australia and A$389.8m from International markets.

Market Cap: A$33.2b

Investors looking at Sigma Healthcare are getting a large scale pharmacy distributor with strong earnings momentum over the past 5 years and revenue forecast to grow faster than the broader Australian market, yet trading only slightly below an estimated fair value. The appeal is that earnings are still projected to grow, but margins and a 12.2% ROE point to a business that must work harder to turn its scale into higher quality returns. A very high P/E and 100% reliance on external borrowing highlight how sensitive the story could be to any stumble, especially with a relatively new management team and board. What matters now is whether that mix of growth, funding risk and fresh leadership justifies a place on your penny stock watchlist.

Sigma Healthcare’s earnings momentum and large scale are hard to ignore, but the tension between growth, funding risk and a very high P/E is where the real story sits. The analyst forecasts for Sigma Healthcare may reveal what the market has not fully priced in yet.

ASX:SIG P/E Ratio as at Jul 2026
ASX:SIG P/E Ratio as at Jul 2026

Stanmore Resources (ASX:SMR)

Overview: Stanmore Resources is a Brisbane based producer of metallurgical coal, supplying steelmakers from a portfolio of mines and exploration tenements across Queensland’s Bowen and Surat basins, with operations run under the ownership of Golden Investments (Australia) Pte. Ltd.

Operations: Stanmore Resources generates about $1.9b in revenue from producing and selling metallurgical and thermal coal, primarily to customers in Asia, Europe, and South America.

Market Cap: A$2.5b

Stanmore Resources stands out in this penny stock list as a coal producer that is currently loss making and is viewed by some analysts as having potential to move into profit over the next few years as cost efficiencies, automation and recent mine investments start to show up in margins. The stock screens as undervalued on several measures, with its share price sitting well below one independent cash flow estimate and analyst targets that are higher than the current A$2.86 price, while still offering a 4.44% dividend yield. The catch is clear: heavy reliance on metallurgical coal, concentrated Queensland assets and exposure to steel demand and regulation mean the risk side of the ledger is just as important as the upside investors are considering.

Stanmore Resources looks like a classic mispriced coal story, where an apparent undervaluation and 4.44% yield could be masking something far more interesting in the 3 key rewards and 1 important warning sign

SMR Discounted Cash Flow as at Jul 2026
SMR Discounted Cash Flow as at Jul 2026

The three penny stocks covered here are just a starting point, with the full Financially Fit Penny Stocks screener surfacing 404 more companies that combine low share prices with financial profiles that could support equally compelling narratives. Use Simply Wall St to identify and analyze the exact catalysts, financial traits and storylines that are most relevant so you can concentrate on the ideas you find most compelling in this corner of the market.

Take Control of Your Investment Journey

If Sigma Healthcare or any of these companies have caught your attention, register for FREE with Simply Wall St and add your companies to a Watchlist to monitor the share price against the fair value and track any new developments as they happen. Once you've made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates. Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives. By uncovering hidden catalysts and risks early, you'll accelerate your decision-making and stay one step ahead of the market.

Seeking Fresh Alternatives Before Momentum Flies

Market momentum can shift quickly, and the best breakout stories rarely stay under the radar for long. Before the crowd catches on and prices start moving, scan these fresh ideas and consider them promptly.

  • Identify resilient cash generators early by reviewing the 12 high quality undiscovered gems that have been filtered for quality, strength, and capacity for the story to develop.
  • Explore structural demand for critical metals by checking the curated 29 best rare earth metal stocks that could be positioned to respond if supply tightens while interest is still building.
  • Evaluate opportunities in infrastructure and electrification trends by reviewing the hand picked 36 power grid technology and infrastructure stocks before short-term traders increase activity in this area.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.